ClinicalTrials.Veeva

Menu

Early Detection of Head and Neck Superficial Squamous Cell Carcinoma in Patients With Esophagus Squamous Cell Carcinoma

S

Shandong University

Status

Unknown

Conditions

Optical Enhancement Endoscopy

Treatments

Device: first WLI
Device: first OE

Study type

Interventional

Funder types

Other

Identifiers

NCT03700398
2017SDU-QILU-06

Details and patient eligibility

About

the investigators randomly divide the eligible objects into two groups:1. objects in this group will first receive OE endoscopy observation and subsequent white light imaging(WLI) observation during oropharynx and hypopharynx; 2. objects in this group will first receive WLI observation and subsequent OE observation during oropharynx and hypopharynx. Then, the investigators will compare the detect rate of oropharyngeal and hypopharyngeal superficial squamous cell carcinoma of two groups to find if OE endoscopy can improve the detect rate of oropharyngeal and hypopharyngeal superficial squamous cell carcinoma in esophageal cancer patients.

Enrollment

214 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • order than 18 years old
  • Previous or current histopathological pathology confirmed the presence of esophageal squamous cell carcinoma

Exclusion criteria

  • Previously confirmed pharynx/oropharyngeal squamous cell carcinoma
  • Advanced pharynx/hypopharyngeal squamous cell carcinoma
  • Pregnant women and lactating women
  • pharyngeal or esophageal stenosis, esophageal varices, or active digestive tract hemorrhage influence the observation or fail to obtain pathological diagnosis
  • Previous chemotherapy or radiation therapy affected observation
  • Not completed gastroscopy or refused to take biopsy for various reasons
  • Mental illnesses such as anxiety and depression affect the endoscopic observation
  • Severe systemic disease, can not tolerate gastroscopy
  • Refusal to sign informed consent books

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

214 participants in 2 patient groups

first OE
Experimental group
Treatment:
Device: first OE
First WLI
Other group
Treatment:
Device: first WLI

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems